register

News & Trends - MedTech & Diagnostics

Private hospital care still in recovery phase while private health insurers post profits

Health Industry Hub | February 24, 2021 |

MedTech News: New data shows patient numbers seeking care in private hospitals were slowly beginning to bounce back toward the end of 2020 after COVID-19 restrictions limited elective surgery, but treatment episodes are still down compared to the same time in 2019.

The latest data from the Australian Prudential Regulation Authority (APRA) showed a 24% increase in episodes of care from the June to December 2020 quarters, illustrating a return to more ‘normal’ levels. However, numbers were still impacted by shut downs in Victoria and short-term restrictions in South Australia.

Australian Private Hospitals Association (APHA) CEO Michael Roff said the sector is providing care to patients, but is still impacted by the pandemic.

“This data shows us an increase in episodes of care in the private sector – some of which will be helping public hospitals battle their large elective surgery waiting lists – but it is still 10% lower than the same period pre-pandemic. There is still some work to be done before the sector is fully recovered.”

According to APRA, the quarterly data shows private health insurance (PHI) posted a profit of more than $341 million in the three months to 31 December 2020, a 205.4% increase on its previous quarterly reporting figures.

Despite these profits and despite spending over $2.4 billion a year on ‘management expenses’ – including executive bonuses, corporate perks and advertising – Australians are still being left to pay 13% more in out-of-pocket costs for their hospital treatments.

Mr Roff said the uptake of private health insurance might change when JobKeeper ends next month.

“There may yet be another blow for health insurance as COVID-19-related income supports are withdrawn. This highlights the need for the Federal Government to assist households to keep their insurance by restoring the rebate for low-income earners in the Budget.

“These households face a ‘double whammy’ of increased premiums and reduced rebates because every year the value of their private health insurance rebate goes down. The Government can provide significant relief to those families and make the rebate count again,” he said.

Medical Technology Association of Australia (MTAA) is concerned insurers are prioritising profits over patients’ needs, forcing many families to seriously consider ditching their private healthcare cover. The medical technology industry is doing its part through its Agreement with the Commonwealth which is delivering savings of $1.1 billion, despite the significant impacts of the pandemic and the suspension of elective surgery in 2020.

Another way Australians could save money on their health insurance is a drop in premiums if deferred claims are not realised.

“The APRA release shows us there is a deferred claims liability of $1.8 million – which is money sitting in the banks of private health insurers expected to be paid out as elective surgery and other procedures catch up post-lockdown.

“If these claims are not made due to capacity restraints, that money should be returned to private health insurance members via reductions in premiums. If insurers are serious about lower premiums for Australians, they will readily agree to this,” Mr Roff said.

In addition, it appears the ‘harvesting’ of privately insured patients in public hospital emergency departments has dropped both over the quarter and over the 12 months to December 2020. This is good news for public patients languishing on waiting lists that are blowing out all over the country due to COVID-19 surgery restrictions.

“These waiting list issues should be a wake-up call for the public hospital system to prioritise access for public patients, not health insurance revenue. Private hospitals have already stepped up to the mark to assist the public system during the pandemic, now that hospitals are returning to ‘normal’ we look forward to seeing public hospital waiting lists reduce along with the number of private patients treated in public hospitals,” concluded Mr Roff.


News & Trends - Pharmaceuticals

Medicines Australia and AusBiotech join Research Australia and DHCRC in welcoming funding for medical research and One Stop Shop

Medicines Australia and AusBiotech join Research Australia and Digital Health CRC in welcoming funding of national strategy for medical research and National One Stop Shop

Health Industry Hub | May 2, 2024 |

Pharma News: Medicines Australia, AusBiotech, Research Australia and the Digital Health Cooperative Research Centre (DHCRC) applaud the funding announcement of […]

More


News & Trends - MedTech & Diagnostics

Health insurers clash with government decision on GUIs, prompting threat of premium hikes

Health insurers clash with government on GUIs decision, prompting threat of premium hikes

Health Industry Hub | May 2, 2024 |

MedTech & Diagnostics News: A warning of potential increases in health insurance premiums for 15 million Australians has been issued […]

More


News & Trends - MedTech & Diagnostics

Catheter ablation underused in atrial fibrillation despite proven efficacy

Catheter ablation underused in atrial fibrillation despite proven efficacy

Health Industry Hub | May 2, 2024 |

MedTech & Diagnostics News: A new study highlights that nearly half of all patients hospitalised for atrial fibrillation (AF) in […]

More


News & Trends - Biotechnology

How prepared are we for the next pandemic?

How prepared are we for the next pandemic?

Health Industry Hub | May 2, 2024 |

Biotech News: The Melbourne biotechnology community came together for a symposium hosted by BioMelbourne and mRNA Victoria, featuring specialists in […]

More


This content is copyright protected. Please subscribe to gain access.